Abstract 447: Anti-tumor efficacy of ompenaclid, a creatine transporter inhibitor, in KRAS mutant tumors, including NSCLC

Authors: PuiChi Lo, Victor Sanz Chavez, Shugaku Takeda, Masoud Tavazoie, Isabel Kurth

Published: 2024-03-22

DOI: 10.1158/1538-7445.am2024-447

Source: Full article

---

Abstract

Abstract